Repurposing DPP-4 Inhibitors for Colorectal Cancer: A Retrospective and Single Center Study

Repurposing DPP-4 Inhibitors for Colorectal Cancer: A Retrospective and Single Center Study

Background: There have been studies reporting the crucial roles of Dipeptidyl-peptidase 4 (DPP4) in colorectal cancer (CRC) initiation and progression, whereas DPP4-inhibitors are safe Food and Drug Association (FDA)-approved drugs for treating diabetes. This study aims to investigate the associatio...

Full description

Bibliographic Details
Main Authors: Lui Ng, Dominic Chi-Chung Foo, Carlos King-Ho Wong, Abraham Tak-Ka Man, Oswens Siu-Hung Lo, Wai-Lun Law
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
colorectal cancer
DPP4
CD26
DPP4-inhibitor
gliptin
immune cell
Online Access:https://www.mdpi.com/2072-6694/13/14/3588

Internet

https://www.mdpi.com/2072-6694/13/14/3588

Similar Items